AI events. Find your people.

⌖ Barcelona · Hotel Catalonia Plaza Catalunya

Hosted by UBIQ Events

The 6th Digital Health Conference brings pharma, MedTech and health-tech leaders to Barcelona on 3–4 November 2026 to examine AI, data and digital medicine. Held at Hotel Catalonia Plaza Catalunya, this two-day industry conference is designed for professionals working across digital health, pharmaceuticals, medical technology, regulation, investment and patient-centred innovation. Its programme combines 20+ sessions, more than 15 keynotes, two group stand-up discussions and networking, including a cocktail night. Attendees will also have access to a dedicated event app. Topics The programme explores the strategic, clinical and commercial questions shaping digital healthcare, including: - AI and data-driven healthcare in pharma - Patient experience and patient-centric digital health - Regulation affecting digital medicine and digital therapeutics - Digital tools in drug development and clinical trials - Remote patient monitoring and evidence of solution performance - Digital biomarkers in neuroscience - AI-powered diagnosis and medical image intelligence - Hybrid care and open, integrated digital ecosystems - Digital transformation within pharma operations Announced speakers include digital health and product leaders from Medtronic, Bayer, Evinova, Abbott, Philips, Roche, Astellas, AstraZeneca, Boehringer Ingelheim, Otsuka and other healthcare organisations. Among them are Roberto Strino, AI Translator and Digital Health Innovation Manager at AstraZeneca; Irenee Colin, Digital Health Director at Medtronic; Ghaith Sankari, Director of Digital Health at Bayer; and Alexandra Kalpadaki-Smith, Associate Director of Digital Science at Evinova. Further speakers are due to be announced. Register for the 6th Digital Health Conference.

⌖ Barcelona

Hosted by UBIQ Events

A director-level pharma conference in Barcelona, 19–20 April 2027, exploring AI across drug discovery, clinical trials and personalised medicine. The 3rd Pharma Meets AI Conference brings pharmaceutical decision-makers together for two focused days on the practical opportunities and difficult questions created by artificial intelligence. Organised by UBIQ Events, this English-language, on-site conference examines how machine learning and data-driven systems are changing the development of medicines,from identifying promising candidates to improving trials and tailoring treatment. What the conference will cover The agenda is built around four closely connected areas: - AI-driven drug discovery, including the role of computational approaches in pharmaceutical research and development - Machine learning in clinical trials and its potential application across the trial process - Personalised medicine, where data and AI can support more individualised approaches to treatment - Regulatory and ethical questions surrounding the adoption of AI in a highly regulated industry These themes make the conference particularly relevant to director-level professionals working across pharma, AI, machine learning, clinical development, data and analytics, and business strategy. The emphasis is on the intersection of technology and pharmaceutical decision-making rather than introductory AI education, making it best suited to experienced attendees assessing implementation, risk and strategic impact. Format and programme More than 16 keynote sessions are planned, each running in a substantial 40-minute slot. This format gives speakers room to develop their ideas beyond short presentations and gives attendees a broad view of current AI applications and debates across the pharmaceutical sector. The full programme is expected in Q4 2026. The event takes place on 19–20 April 2027 at a Barcelona hotel, with the specific venue still to be announced. It will be delivered in English and held entirely in person. Pricing begins at €590 for Super Early Bird tickets, with subsequent ticket tiers rising to €1,590.… Register for this event